Download PDF
Semin Neurol 2005; 25(2): 168-173
DOI: 10.1055/s-2005-871325
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Diabetic Neuropathy

Praful Kelkar1
  • 1Department of Neurology, University of Iowa Hospitals, Iowa City, Iowa
Further Information

Publication History

Publication Date:
03 June 2005 (online)

    Permissions and Reprints

ABSTRACT

Diabetic neuropathy is not a single entity but manifests as several different clinical syndromes. It is likely that different pathophysiological mechanisms contribute to the development of the neuropathy, including metabolic alterations, microvascular changes, and inflammatory changes. A summary of the underlying pathophysiological mechanisms and clinical aspects of different diabetic neuropathies are outlined in this article.

KEYWORDS

Diabetic neuropathy - painful neuropathy - amyotrophy - multifocal neuropathy

REFERENCES

  • 1 Thomas P K, Tomlinson D R. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK Peripheral Neuropathy. Philadelphia; WB Saunders 1993: 1219-1250
    Google Scholar
  • 2 Oates P J. Polyol pathway and diabetic peripheral neuropathy.  Int Rev Neurobiol. 2002;  50 325-392
    PubMedGoogle Scholar
  • 3 Cameron N E, Eaton S E, Cotter M A, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.  Diabetologia. 2001;  44 1973-1988
    CrossrefPubMedGoogle Scholar
  • 4 Thornalley P J. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.  Int Rev Neurobiol. 2002;  50 37-57
    PubMedGoogle Scholar
  • 5 Kelkar P, Masood M, Parry G J. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy).  Neurology. 2000;  55 83-88
    PubMedGoogle Scholar
  • 6 Dyck P J, Windebank A J. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment.  Muscle Nerve. 2002;  25 477-491
    CrossrefPubMedGoogle Scholar
  • 7 Kelkar P, Parry G J. Mononeuritis multiplex in diabetes mellitus: evidence for underlying immune pathogenesis.  J Neurol Neurosurg Psychiatry. 2003;  74 803-806
    CrossrefPubMedGoogle Scholar
  • 8 Said G, Lacroix C, Lozeron P, Ropert A, Plante V, Adams D. Inflammatory vasculopathy in multifocal diabetic neuropathy.  Brain. 2003;  126 376-385
    CrossrefPubMedGoogle Scholar
  • 9 Graham A R, Johnson P C. Direct immunofluorescence findings in peripheral nerve from patients with diabetic neuropathy.  Ann Neurol. 1985;  17 450-454
    CrossrefPubMedGoogle Scholar
  • 10 Krendel D A, Zacharias A, Younger D S. Autoimmune diabetic neuropathy.  Neurol Clin. 1997;  15 959-971
    CrossrefPubMedGoogle Scholar
  • 11 Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy.  Exp Diabesity Res. 2003;  4 271-285
    PubMedGoogle Scholar
  • 12 Hall K E, Liu J, Sima A A, Wiley J W. Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy.  J Neurophysiol. 2001;  86 760-770
    PubMedGoogle Scholar
  • 13 Craner M J, Klein J P, Renganathan M, Black J A, Waxman S G. Changes of sodium channel expression in experimental painful diabetic neuropathy.  Ann Neurol. 2002;  52 786-792
    CrossrefPubMedGoogle Scholar
  • 14 Jamal G A. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy.  Diabet Med. 1994;  11 145-149
    PubMedGoogle Scholar
  • 15 Cameron N E, Cotter M A, Horrobin D H, Tritschler H J. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.  Diabetologia. 1998;  41 390-399
    CrossrefPubMedGoogle Scholar
  • 16 Dyck P J, Kratz K M, Karnes J L et al.. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.  Neurology. 1993;  43 817-824
    CrossrefPubMedGoogle Scholar
  • 17 Pagnanelli D M, Barrer S J. Outcome of carpal tunnel release surgery in patients with diabetes.  Neurosurg Focus. 1997;  3 e9
    PubMedGoogle Scholar
  • 18 Mondelli M, Padua L, Reale F, Signorini A M, Romano C. Outcome of surgical release among diabetics with carpal tunnel syndrome.  Arch Phys Med Rehabil. 2004;  85 7-13
    CrossrefPubMedGoogle Scholar
  • 19 LeRoux P D, Ensign T D, Burchiel K J. Surgical decompression without transposition for ulnar neuropathy: factors determining outcome.  Neurosurgery. 1990;  27 709-714
    PubMedGoogle Scholar
  • 20 Dyck P J, Norell J E, Dyck P J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy.  Neurology. 1999;  53 2113-2121
    CrossrefPubMedGoogle Scholar
  • 21 Llewelyn J G, Thomas P K, King R H. Epineurial microvasculitis in proximal diabetic neuropathy.  J Neurol. 1998;  245 159-165
    PubMedGoogle Scholar
  • 22 Kilfoyle D, Kelkar P, Parry G J. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy.  J Clin Neuromusc Dis. 2003;  4 168-170
    PubMedGoogle Scholar
  • 23 Kelkar P, Hammer-White S. Impaired glucose tolerance in non-diabetic lumbosacral radiculoplexus neuropathy.  Muscle Nerve. 2005;  31 273-274
    PubMedGoogle Scholar
  • 24 Miyasaki H, Hasegawa O, Mori I, Matsumoto S, Arita T. [Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP].  No To Shinkei. 1999;  51 415-418
    PubMedGoogle Scholar
  • 25 Sharma K R, Cross J, Farronay O, Ayyar D R, Shebert R T, Bradley W G. Demyelinating neuropathy in diabetes mellitus.  Arch Neurol. 2002;  59 758-765
    CrossrefPubMedGoogle Scholar
  • 26 Wilson J R, Stittsworth Jr J D, Kadir A, Fisher M A. Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy.  Muscle Nerve. 1998;  21 1228-1230
    CrossrefPubMedGoogle Scholar

Praful KelkarM.D. 

Department of Neurology, 2RCP, University of Iowa Hospitals

200 Hawkins Drive, Iowa City, IA 52242

      >